The phospholipidosis-inducing potential of the chemopotentiating drug, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene) correlates with its stimulation of phosphatidylserine synthesis and exposure on the plasma membrane in MCF-7 breast cancer cells

Proceedings of the Western Pharmacology Society

Volumn 50, Issue , 2007, Pages 61-63

  Xu, Fred Y ^a   Queen, Gary ^a   Brandes, Lorne ^a   Hatch, Grant M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; DIPHENYL ETHER DERIVATIVE; N,N DIETHYL 2 ((4 PHENYLMETHYL)PHENOXY)ETHANAMINE; N,N-DIETHYL-2-((4-PHENYLMETHYL)PHENOXY)ETHANAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; SERINE;

ARTICLE; BIOSYNTHESIS; BLOOD; BREAST TUMOR; CELL MEMBRANE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; LIPIDOSIS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ARACHIDONIC ACID; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; DRUG SYNERGISM; FEMALE; HUMANS; LIPIDOSES; PHENYL ETHERS; PHOSPHATIDYLSERINES; PHOSPHOLIPIDS; SERINE;

EID: 48249126475     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Brandes, L.J., and Hermonant, N.W. (1984) Biochem. Biophys. Res. Commun. 123, 724-728.
2. Saxena, S.P., McNicol, A., Brandes, L.J., Becker, A.B., and Gerrard, J.M. (1989) Biochem. Biophys. Res. Commun. 164, 164-168.
3. Brandes, L.J., LaBella, F.S., Glavin, G.B., Paraskevas, F., Saxena, S.P., McNicol, A., and Gerrard, J.M. (1990) Biochem. Pharmacol. 40, 1677-1681.
4. Brandes, L.J., Labella, F., and Warrington, R.C. (1991) J. Natl. Cancer Inst. 83, 1329-1336.
5. Saxena, S.P., McNicol, A., Becker, A.B. Brandes, L.J., Thastrup, O., and Gerrard, J.M. (1992) Thromb. Haemost. 68, 714-718.
6. Brandes, L.J., Simons, K.J., Bracken, S.P., and Warrington, R.C. (1994) J. Clin. Oncol. 12, 1281-1290.
7. Brandes, L.J., Bracken, S.P., and Ramsey, E.W. (1995) J. Clin. Oncol. 13, 1398-1403.
8. Reyno, L., Seymour, L., Tu, D., Dent, S., Gelmon, K., Walley, B., Pluzanska, A., Gorbunova, V., Garin, A., Jassem, J., Pienkowski, T., Dancey, J., Pearce, L., MacNeil, M., Marlin, S., Lebwohl, D., Voi, M., and Pritchard, K. (2004) J. Clin. Oncol. 22, 269-276.
9. Deli, M.A., Nemeth, L., Falus, A., and Abraham C.S. (2000) Eur. J. Pharmcol. 387, 63-72.
10. Ferguson, L.R., and DeFlora, S. (2005) Mutat. Res. 591, 24-33.
11. Chadderton, A., Villeneuve, D.J., Gluck, G., Kirwan-Rhude, A.F., Gannon, B.R., Blais, D.E., and Parissenti, A.M. (2000) Breast Can. Res. Treat. 59, 231-244.
12. Brandes, L.J., Queen, G., and Labella, F. (2000) Cancer Chemother. Pharmacol. 45, 298-304.
13. Breckenridge, C., and Lazier, C.B. (1987) Lipids 22, 505-512.
14. Lazier, C.B., and Breckenridge, C. (1990) Biochem. Cell Biol. 68, 210-217.
15. White, D.A. (1973) Phospholipids. In Ansell, G.B., Hawthorne, J.N. and Dawson, R.M.C., editors. Form and Function of Phospholipids. Elsevier, Amsterdam.
16. Fadock, V.A., Bratton, D.L., Frasch, S.C., Warner, M.L., and Henson, P.M. (1998) Cell Death Differ. 5, 551-562.
17. Elliot, J.I., Raquz, S., and Higgins, C.F. (2005) Brit. J. Pharmacol. 143, 899-907.
18. Hatch, G.M., and McClarty, G. (1996) J. Biol. Chem. 271, 25810-25816.
19. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) J. Biol. Chem. 193, 265-275.
20. Kasahara, T., Tomita, K., Murano, H., Harada, T., Tsubakimoto, K., Ogihara, T., Ohnishi, S., and Kakinuma, C. (2006) Toxicol Sci. 90, 133-141.